Cardiorenal Syndrome in a Patient with Mechanical Circulatory Support

[1]  M. Mehra,et al.  Magnetically Levitated Cardiac Pump at 2 Years. , 2018, The New England journal of medicine.

[2]  V. Rao,et al.  Magnetically Levitated Cardiac Pump at 2 Years. , 2018, The New England journal of medicine.

[3]  James W Long,et al.  Two‐Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure , 2018, The New England journal of medicine.

[4]  W. Shimizu,et al.  Worsening renal function definition is insufficient for evaluating acute renal failure in acute heart failure , 2018, ESC heart failure.

[5]  D. Weiner,et al.  Left Ventricular Assist Devices, Kidney Disease, and Dialysis. , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[6]  G. Stevens,et al.  Left Ventricular Assist Devices and the Kidney. , 2017, Clinical journal of the American Society of Nephrology : CJASN.

[7]  F. Verbrugge,et al.  Renal sodium avidity in heart failure: from pathophysiology to treatment strategies , 2017, European heart journal.

[8]  N. Uriel,et al.  Left Ventricular Assist Devices for Lifelong Support. , 2017, Journal of the American College of Cardiology.

[9]  J. Butler,et al.  The Cardio-Renal Interrelationship. , 2017, Progress in cardiovascular diseases.

[10]  Finn Gustafsson,et al.  Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes , 2017, European journal of heart failure.

[11]  Y. Naka,et al.  Changes in End-Organ Function in Patients With Prolonged Continuous-Flow Left Ventricular Assist Device Support. , 2017, The Annals of thoracic surgery.

[12]  Gregory A. Ewald,et al.  A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure , 2017, The New England journal of medicine.

[13]  Bhavesh M. Patel,et al.  Mechanical circulatory assist devices: a primer for critical care and emergency physicians , 2016, Critical Care.

[14]  J. Pacholewicz,et al.  Effects of Left Ventricular Assist Device Support on End-Organ Function in Patients With Heart Failure: Comparison of Pulsatile- and Continuous-Flow Support in a Single-Center Experience. , 2016, Transplantation proceedings.

[15]  T. Ahmad,et al.  Reduced Cardiac Index Is Not the Dominant Driver of Renal Dysfunction in Heart Failure. , 2016, Journal of the American College of Cardiology.

[16]  Konstantinos Makris,et al.  Acute Kidney Injury: Definition, Pathophysiology and Clinical Phenotypes. , 2016, The Clinical biochemist. Reviews.

[17]  M. Moulton,et al.  Outcomes in Patients with Severe Preexisting Renal Dysfunction After Continuous-Flow Left Ventricular Assist Device Implantation , 2016, ASAIO journal.

[18]  J. Fraser,et al.  The Complex Relationship of Extracorporeal Membrane Oxygenation and Acute Kidney Injury: Causation or Association? , 2016, BioMed research international.

[19]  J. Teuteberg,et al.  Right ventricular failure after left ventricular assist devices. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[20]  K. Damman,et al.  The kidney in heart failure: an update. , 2015, European heart journal.

[21]  N. de Jonge,et al.  Left ventricular assist devices: a kidney’s perspective , 2015, Heart Failure Reviews.

[22]  M. Keebler,et al.  Kidney Dysfunction and Left Ventricular Assist Device Support: A Comprehensive Perioperative Review , 2015, Cardiorenal Medicine.

[23]  K. Muthiah,et al.  Normalisation of haemodynamics in patients with end-stage heart failure with continuous-flow left ventricular assist device therapy. , 2014, Heart, lung & circulation.

[24]  D. Burkhoff,et al.  Evolution of Renal Function after Partial and Full Mechanical Support for Chronic Heart Failure , 2014, The International journal of artificial organs.

[25]  J. Stulak,et al.  Hepatic and renal function with successful long-term support on a continuous flow left ventricular assist device. , 2014, Heart, Lung and Circulation.

[26]  C. O'connor,et al.  Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. , 2014, European heart journal.

[27]  C. Ronco,et al.  Implantable Left Ventricular Assist Devices and the Kidney , 2014, Blood Purification.

[28]  S. Kimmel,et al.  Prevalence and Prognostic Importance of Changes in Renal Function After Mechanical Circulatory Support , 2014, Circulation. Heart failure.

[29]  L. Stevenson,et al.  Quantifying the effect of cardiorenal syndrome on mortality after left ventricular assist device implant. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[30]  M. Guglin,et al.  Patient selection for ventricular assist devices: a moving target. , 2013, Journal of the American College of Cardiology.

[31]  M. Rudnick,et al.  Renal failure in patients with left ventricular assist devices. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[32]  C. Ronco,et al.  Effect of Percutaneous Ventricular Assist Devices on Renal Function , 2013, Blood Purification.

[33]  A. Diedrich,et al.  Patients With Continuous-Flow Left Ventricular Assist Devices Provide Insight in Human Baroreflex Physiology , 2012, Hypertension.

[34]  S. Miyagawa,et al.  Predictor of early mortality for severe heart failure patients with left ventricular assist device implantation: significance of INTERMACS level and renal function. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[35]  J. Butler,et al.  The cardiorenal syndrome in heart failure: cardiac? renal? syndrome? , 2012, Heart Failure Reviews.

[36]  M. Givertz,et al.  Mechanical Circulatory Support for Advanced Heart Failure: Patients and Technology in Evolution , 2012, Circulation.

[37]  G. Ewald,et al.  Outcomes in Advanced Heart Failure Patients With Left Ventricular Assist Devices for Destination Therapy , 2012, Circulation. Heart failure.

[38]  R. Rodeheffer,et al.  Changes in renal function after implantation of continuous-flow left ventricular assist devices. , 2012, Journal of the American College of Cardiology.

[39]  M. Metra,et al.  Is Worsening Renal Function an Ominous Prognostic Sign in Patients With Acute Heart Failure?: The Role of Congestion and Its Interaction With Renal Function , 2012, Circulation. Heart failure.

[40]  J. Butler,et al.  Renal function in advanced heart failure. , 2011, Congestive heart failure.

[41]  Yoshifumi Naka,et al.  Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). , 2011, Journal of the American College of Cardiology.

[42]  H. Lan,et al.  Chemokines in renal injury. , 2011, Journal of the American Society of Nephrology : JASN.

[43]  M. Simon,et al.  Impact of renal function before mechanical circulatory support on posttransplant renal outcomes. , 2011, The Annals of thoracic surgery.

[44]  Adrian F Hernandez,et al.  Diuretic strategies in patients with acute decompensated heart failure. , 2011, The New England journal of medicine.

[45]  Z. Demirozu,et al.  Results of HeartMate II left ventricular assist device implantation on renal function in patients requiring post-implant renal replacement therapy. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[46]  M. Dew,et al.  Early adverse events as predictors of 1-year mortality during mechanical circulatory support. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[47]  Russell C Davis,et al.  Loop diuretic therapy in left ventricular systolic dysfunction: has familiarity bred contempt for a critical but potentially nephrotoxic cardio renal therapy? , 2010, European journal of heart failure.

[48]  A. Hoffmeier,et al.  Effect of pulsatile and non-pulsatile left ventricular assist devices on the renin-angiotensin system in patients with end-stage heart failure. , 2010, The Thoracic and cardiovascular surgeon.

[49]  S. Russell,et al.  Advanced heart failure treated with continuous-flow left ventricular assist device. , 2009, The New England journal of medicine.

[50]  Francis D. Pagani,et al.  Renal and Hepatic Function Improve in Advanced Heart Failure Patients During Continuous-Flow Support With the HeartMate II Left Ventricular Assist Device , 2009, Circulation.

[51]  O. Frazier,et al.  TandemHeart as a rescue therapy for patients with critical aortic valve stenosis. , 2009, The Annals of thoracic surgery.

[52]  V. Rao,et al.  Predictors of acute renal dysfunction after ventricular assist device placement. , 2009, Journal of cardiac failure.

[53]  Diana Elbourne,et al.  Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial , 2009, The Lancet.

[54]  Daniel Levy,et al.  Relation of Disease Pathogenesis and Risk Factors to Heart Failure With Preserved or Reduced Ejection Fraction: Insights From the Framingham Heart Study of the National Heart, Lung, and Blood Institute , 2009, Circulation.

[55]  M. Rothman,et al.  A first‐in‐man study of the reitan catheter pump for circulatory support in patients undergoing high‐risk percutaneous coronary intervention , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[56]  D. Dunkler,et al.  Renal function and outcome after continuous flow left ventricular assist device implantation. , 2009, The Annals of thoracic surgery.

[57]  Gary S Francis,et al.  Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. , 2009, Journal of the American College of Cardiology.

[58]  S. Vecchio,et al.  Use of Impella Recover 2.5 left ventricular assist device in patients with cardiogenic shock or undergoing high-risk percutaneous coronary intervention procedures: experience of a high-volume center. , 2008, Minerva cardioangiologica.

[59]  William A. Smith,et al.  Reduced pulsatility induces periarteritis in kidney: role of the local renin-angiotensin system. , 2008, The Journal of thoracic and cardiovascular surgery.

[60]  A. Hørlyck,et al.  Intra-aortic balloon pumping increases renal blood flow in patients with low left ventricular ejection fraction , 2008, Perfusion.

[61]  Ernst Wolner,et al.  Renal function after implantation of continuous versus pulsatile flow left ventricular assist devices. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[62]  S. Buscemi,et al.  Oxidative stress, inflammation and cardiovascular disease in chronic renal failure. , 2008, Journal of nephrology.

[63]  Andrew Boyle,et al.  Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[64]  M. Metra,et al.  Worsening renal function in patients hospitalised for acute heart failure: Clinical implications and prognostic significance , 2008, European journal of heart failure.

[65]  John G F Cleland,et al.  Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. , 2007, Journal of cardiac failure.

[66]  D. J. Veldhuisen,et al.  Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction , 2007, European journal of heart failure.

[67]  D. Levy,et al.  Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control. , 2006, Archives of internal medicine.

[68]  Harlan M Krumholz,et al.  Renal impairment and outcomes in heart failure: systematic review and meta-analysis. , 2006, Journal of the American College of Cardiology.

[69]  R. Pierson,et al.  Relationship between renal function and left ventricular assist device use. , 2006, The Annals of thoracic surgery.

[70]  M. Oz,et al.  Predictors and outcomes of continuous veno-venous hemodialysis use after implantation of a left ventricular assist device. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[71]  Michael S. Lee,et al.  Percutaneous left ventricular assist device: “TandemHeart” for high‐risk coronary intervention , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[72]  R. Bellomo,et al.  Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group , 2004, Critical care.

[73]  P. Armstrong,et al.  Renal Insufficiency and Heart Failure: Prognostic and Therapeutic Implications From a Prospective Cohort Study , 2004, Circulation.

[74]  N. Smedira,et al.  Severe renal dysfunction complicating cardiogenic shock is not a contraindication to mechanical support as a bridge to cardiac transplantation. , 2003, Journal of the American College of Cardiology.

[75]  M C Oz,et al.  Long-term use of a left ventricular assist device for end-stage heart failure. , 2001, The New England journal of medicine.

[76]  N. Smedira,et al.  Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure: survival at five years. , 2001, The Journal of thoracic and cardiovascular surgery.

[77]  R. Hetzer,et al.  Outcome of patients with ventricular assist devices and acute renal failure requiring renal replacement therapy. , 2000, ASAIO journal.

[78]  P. Agostoni,et al.  Isolated ultrafiltration in moderate congestive heart failure. , 1993, Journal of the American College of Cardiology.

[79]  M. Metra,et al.  Cardiorenal Interactions. , 2016, Heart failure clinics.

[80]  Nader Moazami,et al.  Unexpected abrupt increase in left ventricular assist device thrombosis. , 2014, The New England journal of medicine.

[81]  J. Laragh,et al.  Role of the Kidney in Congestive Heart Failure , 2012, Drugs.

[82]  P. Centofanti,et al.  Posterior ventricular septal defect in presence of cardiogenic shock: early implantation of the impella recover LP 5.0 as a bridge to surgery. , 2011, Texas Heart Institute journal.

[83]  B. Kiaii,et al.  Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock. , 2004, The Annals of thoracic surgery.

[84]  B. Griffith,et al.  Smooth muscle cell hypertrophy of renal cortex arteries with chronic continuous flow left ventricular assist. , 2003, The Annals of thoracic surgery.